# K071202: Dermaport Percutaneous Vascular Access System (Pvas)

- Pathway: 510(k) (Abbreviated)
- Applicant: Dermaport, Inc.
- Decided: Nov 30, 2007 after 213 days
- Product code: MSD (Catheter, Hemodialysis, Implanted)
- Device class: 2
- Regulation: 21 CFR 876.5540
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 5 generations back to K013160 (2002). 9 ancestors in all.
1 later device descends from it; 1 cites it directly.
0 of 11 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K994105: Hemo-Flow Double Lumen Catheter, Models HFS-24, HFS-28, HFS-32, HFS-36, HFS-40, Medical Components, Inc. (2001) Summary page 1.
- K062901: Hemocath II, Med-Conduit, Inc. (2007) Summary page 1.

## Most influential descendants
- K091760: Dermaport Ported Vascular Access System (Pvas) (2009), 0 descendants of its own

## Indications for use
The DermaPort Percutaneous Vascular Access Syster (PVAS™) is indicated for long-term (greater than 30 days) vascular access for hemodialysis and apheresis. The system is inscrted percutaneously and the catheter is typically placed in the internal jugular vein of an adult patient. The subclavian vein is an alternate catheter insertion site.

Source page: https://510kreport.com/device/K071202
Methodology: https://510kreport.com/methodology